Total planned funding: $168,227,649
Allocations
Countries/Regions
India | $168,227,649 |
Organizational Types
Unknown | $98,015,899 |
NGO | $33,850,064 |
Own Agency | $19,065,389 |
University | $8,090,217 |
Private Contractor | $3,198,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $1,506,808 |
Host Country Government Agency | $1,201,000 |
FBO | $200,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $70,924,632 |
Prevention | $39,248,871 |
Care | $19,969,341 |
Management and Operations | $16,433,849 |
Testing | $10,163,116 |
Treatment | $7,060,048 |
Budget Codes
OHSS: Health Systems Strengthening | $44,300,558 |
HVSI: Strategic Information | $22,698,078 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,953,781 |
HVMS: Management and Operations | $16,433,849 |
HBHC: Care: Adult Care and Support | $14,196,029 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,813,755 |
HVCT: Testing: HIV Testing and Counseling | $10,163,116 |
HTXS: Treatment: Adult Treatment | $6,931,188 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,051,259 |
HKID: Care: Orphans and Vulnerable Children | $4,569,112 |
HLAB: Laboratory Infrastructure | $3,925,996 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,430,076 |
HVTB: Care: TB/HIV | $944,183 |
PDCS: Care: Pediatric Care and Support | $260,017 |
PDTX: Treatment: Pediatric Treatment | $128,860 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$98,015,899
Countries/Regions
USG Aggregated Agencies:
$18,188,527
Countries/Regions
FHI 360:
$15,442,311
Countries/Regions